Drug Profile
Research programme: melanocortin-4 receptor agonists - Melacure Therapeutics
Alternative Names: melanocortin-4 receptor agonists research programme - Melacure TherapeuticsLatest Information Update: 02 Aug 2006
Price :
$50
*
At a glance
- Originator Melacure Therapeutics (CEASED)
- Class
- Mechanism of Action Melanocortin type 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 02 Aug 2006 No development reported - Preclinical for Diabetes mellitus in Sweden (unspecified route)
- 02 Aug 2006 No development reported - Preclinical for Obesity in Sweden (unspecified route)
- 17 Jul 2003 Preclinical trials in Diabetes mellitus in Sweden (unspecified route)